NVNOW logo

enVVeno Medical (NVNOW) Stock

Profile

Full Name:

enVVeno Medical Corporation

Sector:

Healthcare

Country:

United States

IPO:

14 June 2018

Indexes:

Not included

Description:

enVVeno Medical Corporation, a clinical med-tech company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of chronic venous disease. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with NVNOW included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Similar stocks

FAQ

  • What is the primary business of enVVeno Medical?
  • What is the ticker symbol for enVVeno Medical?
  • Does enVVeno Medical pay dividends?
  • What sector is enVVeno Medical in?
  • What industry is enVVeno Medical in?
  • What country is enVVeno Medical based in?
  • When did enVVeno Medical go public?
  • Is enVVeno Medical in the S&P 500?
  • Is enVVeno Medical in the NASDAQ 100?
  • Is enVVeno Medical in the Dow Jones?
  • When does enVVeno Medical report earnings?

What is the primary business of enVVeno Medical?

enVVeno Medical Corporation, a clinical med-tech company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of chronic venous disease. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

What is the ticker symbol for enVVeno Medical?

The ticker symbol for enVVeno Medical is NASDAQ:NVNOW

Does enVVeno Medical pay dividends?

No, enVVeno Medical does not pay dividends

What sector is enVVeno Medical in?

enVVeno Medical is in the Healthcare sector

What industry is enVVeno Medical in?

enVVeno Medical is in the Medical Devices industry

What country is enVVeno Medical based in?

enVVeno Medical is headquartered in United States

When did enVVeno Medical go public?

enVVeno Medical's initial public offering (IPO) was on 14 June 2018

Is enVVeno Medical in the S&P 500?

No, enVVeno Medical is not included in the S&P 500 index

Is enVVeno Medical in the NASDAQ 100?

No, enVVeno Medical is not included in the NASDAQ 100 index

Is enVVeno Medical in the Dow Jones?

No, enVVeno Medical is not included in the Dow Jones index

When does enVVeno Medical report earnings?

The date for enVVeno Medical's next earnings report has not been announced yet